Ligand Pharmaceuticals Incorporated (LGND) NASDAQ
201.66
+1.3(+0.65%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
201.66
+1.3(+0.65%)
Currency In USD
| Market Cap | 3.66B |
| Enterprise Value | 3.93B |
| P/E Ratio | 31.96 |
| PEG Ratio | 0.2 |
| Price/Sales Ratio | 15 |
| Price/Book Ratio | 3.91 |
| Enterprise/Revenue | 16.03 |
| Enterprise/EBITDA | 21.93 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0.46 |
| Operating Margin | 0.18 |
| Return On Assets | 0.08 |
| Return On Equity | 0.14 |
| Revenue | 268.09M |
| Revenue/Share | 13.59 |
| Gross Profit | 261.5M |
| EBITDA | 192.74M |
| Net Income | 124.45M |
| Diluted EPS | 6.13 |
| Total Cash | 733.52M |
| Total Cash/Share | 37.19 |
| Total Debt | 451.49M |
| Total Debt/Equity | 0.44 |
| Current Ratio | 22.23 |
| Book Value Per Share | 51.57 |
| 52-Week Change | 80.59 |
| 52-Week High | 227.92 |
| 52-Week Low | 93.58 |
| Moving Average 50 Days | 197.85 |
| Moving Average 200 Days | 172.55 |
| Average Volume | 216,459 |
| Shares Outstanding | 19.94M |
| % Held by Institutions | 106.04 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1603:1000 |
| Last Split Date | November 02, 2022 |